Early use of steroids affects immune cells and impairs immunotherapy efficacy
Open Access
- 1 January 2019
- journal article
- editorial
- Published by Elsevier BV in ESMO Open
- Vol. 4 (1), e000477
- https://doi.org/10.1136/esmoopen-2018-000477
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitorsESMO Open, 2018
- Early Use of Systemic Corticosteroids in Patients with Advanced NSCLC Treated with NivolumabJournal of Thoracic Oncology, 2018
- Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals Of Oncology, 2018
- Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung CancerJournal of Clinical Oncology, 2018
- Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients' selectionCritical Reviews in Oncology/Hematology, 2018
- Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung CancerCancer Cell, 2018
- Neutrophil to Lymphocyte Ratio in Castration-Resistant Prostate Cancer Patients Treated With Daily Oral CorticosteroidsClinical Genitourinary Cancer, 2017
- Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint BlockadeCancer Discovery, 2016
- Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: a propensity score-matched analysisESMO Open, 2016
- Single-Cell RNA Sequencing Reveals T Helper Cells Synthesizing Steroids De Novo to Contribute to Immune HomeostasisCell Reports, 2014